Kerecis Closes $16M Series C Funding
Summary
Kerecis, a Reykjavik, Iceland and Arlinton, VA-based developer of fish-skin wound treatment, completed a $16m Series C funding round. The company sold shares valued at $10m to new and existing investors. The company will use the proceeds to conduct sales and marketing activities especially in the U.S. and Switzerland. Led by G. Fertram Sigurjonsson, founder and CEO, Kerecis develops patented fish-skin products to heal human wounds and tissue damage. The company’s fish skin retains its similarity to human skin, making it an ideal substitute for it, and contains Omega3 fatty acids, which enhance wound healing.
Funding
Amount
-
Total raised
Date
-
Announcement date
Investors
Kerecis
Lead investors
Company
-
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected